Serum Amyloid A to Albumin Ratio as a Biomarker of Disease Activity in Systemic Lupus Erythematosus
Indian Journal of Rheumatology · 23.06.2026
DOI: 10.1177/09733698261453997 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Rheumatology, online erschienen am 23.06.2026. Verfasst von Esraa Khalid und 3 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease. Effective evaluation of activity indexes is very important in disease management. Serum amyloid A (SAA) is one of the acute-phase reactants. Serum albumin is a negative phase reactant protein; lower than normal levels have been frequently reported in SLE. Hypoalbuminemia is a consequence of the inflammatory process. This study is to evaluate the SAA-to-albumin ratio in SLE patients as a marker of activity.
Results
This study was performed on 25 SLE patients and 25 matched healthy subjects, who underwent detailed history taking, clinical assessment and disease activity assessment using the SLE Disease Activity Index (SLEDAI). The SAA to serum albumin ratio was significantly increased in SLE patients compared to controls ( P < .001). There was a significantly positive correlation between SAA-to-albumin ratio (SAA/ALB) and SLEDAI, complement (C)3 and 24-hrs urinary proteins ( P < .05), while there was no significant correlation between SAA/ALB and ESR, CRP, C4 and Anti-dsDNA ( P > .05).
Conclusions
The SAA/ALB was associated with high disease activity in SLE patients. The SAA/ALB might be an indicator of increased disease activity in SLE.
Zitieren
APA
Khalid, E., Khaled, H. F., Ibrahim, S. E., & Safar, A. (2026). Serum Amyloid A to Albumin Ratio as a Biomarker of Disease Activity in Systemic Lupus Erythematosus. Indian Journal of Rheumatology. https://doi.org/10.1177/09733698261453997
Vancouver
Khalid E, Khaled HF, Ibrahim SE, Safar A. Serum Amyloid A to Albumin Ratio as a Biomarker of Disease Activity in Systemic Lupus Erythematosus. Indian Journal of Rheumatology. 2026. doi:10.1177/09733698261453997
BibTeX
@article{Khalid2026,
author = {Khalid, Esraa and Khaled, Henaz Farouk and Ibrahim, Soha EIdessouki and Safar, Aya},
title = {Serum Amyloid A to Albumin Ratio as a Biomarker of Disease Activity in Systemic Lupus Erythematosus},
journal = {Indian Journal of Rheumatology},
year = {2026},
doi = {10.1177/09733698261453997}
}
EUVIMED